Rheumatoid Arthritis Treatment Guidelines

Mazano ekushandiswa kweDMARD uye Biologic Zvinodhaka

Muna 2012, American College of Rheumatology (ACR) yakarongedza mazano ekurapa rheumatoid arthritis . Nema2011 ACR mazano ekushandiswa kwezvirwere-kuchinja zvinorwisa-rheumatic drugs (DMARDs) uye biologic zvinodhaka zverheumatoid arthritis ndeyekuvandudzwa kwezvirongwa zve2008.

Zvinyorwa zve2012 zvakataurirwa:

  1. izvo zvinoratidza kutanga kana kushandura DMARD uye biologic zvinodhaka
  1. kushandiswa kwezvigadzirwa zvebiologics muvanhu vane ngozi yakawanda, kusanganisira avo vane hepatitis, congestive moyo kusakwanisa, uye kuipa
  2. chirwere chepachifu chekuongorora zvirwere kune vatachiri vanotanga kana kuti ikozvino kutora zvinodhaka zvebiologic
  3. vaccination muvarwere vanotanga kana kuti ikozvino vachitora DMARD kana biologic zvinodhaka

Mazano acho aibva pamabhuku ekutsvakurudza kwePublicMed uye Cochrane Database yeChechi dzeKubvunzurudza, kuongororwa kwemamiriro ekurapa, uye nyanzvi maonero. Mabhuku acho aitsvaga 8 DMARD: azathioprin (Imuran), cyclosporine , hydroxychloroquine (Plaquenil), leflunomide (Arava), methotrexate , minocycline (Minocin), ndarama , uye sulfasalazine (Azulfidine) uye 9 biologic zvinodhaka: abatacept (Orencia) , adalimumab (Humira), anakinra (Kineret), certolizumab pegol (Cimzia), etanercept (Enbrel), golimumab (Simponi), infliximab (Remicade), rituxab (Rituxan), uyecilizumab (Actemra). Nokuda kwekushandisa kusinganzwisisiki kwemishonga uye kusasha kwemashoko matsva akawanikwa kubva kutsvaga, azathioprine, cyclosporine, ndarama, uye anakinra dzakanga dzisingabatanidzwi mukurumbidzwa.

Orencia, Rituxan, Kineret, uye Actemra havasi-TNF biologic zvinodhaka. Enbrel, Remicade, Humira, Simponi, uye Cimzia vane TNF blockers.

Kune varwere vane rheumatoid arthritis yepakutanga (inotsanangurwa seine rheumatoid arthritis kwemwedzi inopfuura 6) uye varwere vane rheumatoid arthritis inorapwa chero chero DMARD kana biologic drug, chinangwa chekurapa chirwere chechiito chakanyanya kana kuti kuregererwa.

Kutanga kana Kushandura DMARD uye Biologic Zvinodhaka

Kushandisa Biologics muRheumatoid Arthritis Patients With Hepatitis, Malignancy, kana Congestive Heart Failure

Tuberculosis (TB) Kuongorora

Vaccination for Patients Kutanga kana Kuwana DMARD kana Biologic Zvinodhaka

ZVAKAITIKA - 2015 ACR Mirayiridzo yekurapa Rheumatoid Arthritis

Nhungamiro iyi yakabudiswazve muna 2015 sechadzokorora kumitemo ye2012. I 2015 nhungamiro inoshandisa kushandiswa kwetsika zvirwere-kuchinja antirheumatic drugs (DMARDs), biologic agents, Xeljanz (tofacitinib) , uye glucocorticoids mukutanga (pasi pemwedzi 6) uye yakagadzirwa (mwedzi 6 kana kupfuura) rheumatoid arthritis. Yakapiwawo muna 2015 nhungamiro inopa mazano ekushandisa nzira yekubata-kutarisa , kushandura nekurega mishonga, uye kushandisa biologic agents uye DMARD kune varwere vane hepatitis, congestive moyo kusakundikana, kuipa, uye zvirwere zvakakomba.

Nhungamiro inoshandisa kushandiswa kwemishonga muvatachiri vanotanga kana kugamuchira DMARD kana biologic zvinodhaka, kuongororwa kwechirwere chetachiona muvatachiri vanotanga kana kugamuchira biologic agents kana tofacitinib, uye kuongororwa kwebato reDMARD. Iyo nhungamiro inosanganisira 74 mazano ayo 23% anoonekwa seakasimba uye 77% inogumira. Iwe unogona kuzviwana pano: 2015 American College of Rheumatology Guideline yekurapa kweRheumatoid Arthritis.

Kunobva:

Kuvandudzwa kwe2008 Mazano ekushandisa kweDMARD uye Biologics mukurapa kweRheumatoid Arthritis. Arthritis Care & Research. pp. 625-639. Singh JA et al. May 2012.
http://onlinelibrary.wiley.com/doi/10.1002/acr.21641/abstract

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Singh JA et al. Arthritis Care & Research DOI 10.1002 / acr.22783
http://www.rheumatology.org/Portals/0/Files/ACR%202015%20RA%20Guideline.pdf